These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36789106)

  • 61. Heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE).
    Xu D; Young J; Song D; Esko JD
    J Biol Chem; 2011 Dec; 286(48):41736-41744. PubMed ID: 21990362
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.
    Prasad K
    Int J Angiol; 2014 Mar; 23(1):11-6. PubMed ID: 24627612
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The receptor for advanced glycation end-products enhances lung epithelial wound repair: An in vitro study.
    Zhai R; Blondonnet R; Ebrahimi E; Belville C; Audard J; Gross C; Choltus H; Henrioux F; Constantin JM; Pereira B; Blanchon L; Sapin V; Jabaudon M
    Exp Cell Res; 2020 Jun; 391(2):112030. PubMed ID: 32330509
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ectodomain Shedding of RAGE and TLR4 as a Negative Feedback Regulation in High-Mobility Group Box 1-Activated Aortic Endothelial Cells.
    Yang WS; Kim JJ; Lee MJ; Lee EK; Park SK
    Cell Physiol Biochem; 2018; 51(4):1632-1644. PubMed ID: 30497069
    [TBL] [Abstract][Full Text] [Related]  

  • 65. RAGE in circulating immune cells is fundamental for hippocampal inflammation and cognitive decline in a mouse model of latent chronic inflammation.
    Ye D; Miyoshi A; Ushitani T; Kadoya M; Igeta M; Konishi K; Shoji T; Yasuda K; Kitaoka S; Yagi H; Kuroda E; Yamamoto Y; Cheng J; Koyama H
    Brain Behav Immun; 2024 Feb; 116():329-348. PubMed ID: 38142917
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
    Nguyen AH; Detty SQ; Agrawal DK
    Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HMGB1/RAGE pro-inflammatory axis promotes vascular endothelial cell apoptosis in limb ischemia/reperfusion injury.
    Mi L; Zhang Y; Xu Y; Zheng X; Zhang X; Wang Z; Xue M; Jin X
    Biomed Pharmacother; 2019 Aug; 116():109005. PubMed ID: 31136947
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients.
    Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Yasuda T; Yamasaki Y
    Diab Vasc Dis Res; 2008 Sep; 5(3):190-7. PubMed ID: 18777492
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients.
    Yan XX; Lu L; Peng WH; Wang LJ; Zhang Q; Zhang RY; Chen QJ; Shen WF
    Atherosclerosis; 2009 Aug; 205(2):544-8. PubMed ID: 19150066
    [TBL] [Abstract][Full Text] [Related]  

  • 70. STAT3 activation promotes oncolytic HSV1 replication in glioma cells.
    Okemoto K; Wagner B; Meisen H; Haseley A; Kaur B; Chiocca EA
    PLoS One; 2013; 8(8):e71932. PubMed ID: 23936533
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Remarkable Roles of the Receptor for Advanced Glycation End Products (RAGE) and Its Soluble Isoforms in COVID-19: The Importance of RAGE Pathway in the Lung Injuries.
    Salehi M; Amiri S; Ilghari D; Hasham LFA; Piri H
    Indian J Clin Biochem; 2023 Apr; 38(2):159-171. PubMed ID: 35999871
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases.
    Chen X; Han J; Chu J; Zhang L; Zhang J; Chen C; Chen L; Wang Y; Wang H; Yi L; Elder JB; Wang QE; He X; Kaur B; Chiocca EA; Yu J
    Oncotarget; 2016 May; 7(19):27764-77. PubMed ID: 27050072
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways.
    Nakajima S; Ogawa N; Yokoue N; Tachibana H; Tamada K; Okazawa M; Sato A; Oyama T; Abe H; Kamiya T; Yoshimori A; Yoshizawa K; Inoue S; Yokomizo T; Uchiumi F; Abe T; Tanuma SI
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1155-1161. PubMed ID: 33041002
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oncolytic herpes simplex virus infects myeloma cells
    Ghose J; Dona A; Murtadha M; Gunes EG; Caserta E; Yoo JY; Russell L; Jaime-Ramirez AC; Barwick BG; Gupta VA; Sanchez JF; Sborov DW; Rosen ST; Krishnan A; Boise LH; Kaur B; Hofmeister CC; Pichiorri F
    Mol Ther Oncolytics; 2021 Mar; 20():519-531. PubMed ID: 33738338
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interplay between RAGE and TLR4 Regulates HMGB1-Induced Inflammation by Promoting Cell Surface Expression of RAGE and TLR4.
    Zhong H; Li X; Zhou S; Jiang P; Liu X; Ouyang M; Nie Y; Chen X; Zhang L; Liu Y; Tao T; Tang J
    J Immunol; 2020 Aug; 205(3):767-775. PubMed ID: 32580932
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms.
    Grossin N; Wautier MP; Picot J; Stern DM; Wautier JL
    Diabetes Metab; 2009 Nov; 35(5):410-7. PubMed ID: 19815443
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.
    Kanai R; Wakimoto H; Martuza RL; Rabkin SD
    Clin Cancer Res; 2011 Jun; 17(11):3686-96. PubMed ID: 21505062
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High-mobility Group Box 1 Contributes to Hypoxic-Ischemic Brain Damage by Facilitating Imbalance of Microglial Polarization through RAGE-PI3K/Akt Pathway in Neonatal Rats.
    Sun Y; Zhu X; Zhu K; Yu J; Cheng L; Hei M
    Int J Med Sci; 2022; 19(14):2093-2103. PubMed ID: 36483598
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
    Riuzzi F; Sorci G; Donato R
    J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway.
    Huang W; Zhao H; Dong H; Wu Y; Yao L; Zou F; Cai S
    Int J Mol Med; 2016 May; 37(5):1189-98. PubMed ID: 27035254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.